There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The weekly epidemiological record of the World Health Organisation 15th May 2015
1
states that ‘the cases of Middle East Respiratory Syndrome (MERS) recently exported
to other countries have not resulted in sustained onward transmission to persons in
close contact with these cases on aircraft or in the respective countries outside
the Middle East.’ This situation has changed rapidly and remarkably. Five days after
the publication of this report, the first case of a MERS-coronavirus (MERS-CoV) infection
in Seoul, South Korea was reported on 20 May 2015
2
. This patient had a history of recent travel to the Middle East. Over the ensuing
three weeks, the number of secondary, tertiary and perhaps quaternary cases of MERS
from this single patient rose rapidly and has become the largest case cluster of MERS
occurring outside the Middle East. The Korean outbreak appears from the available
data to be attributable to poor infection control measures, although the hospital
air-conditioning system's lack of ventilators may have resulted in the rapid extensive
spread of MERS among patients and staff
3
. Furthermore, MERS-CoV was detected in bathrooms and on doorknobs indicating ineffective
disinfection procedures.
As of June 9th 2015, there have been 95 cases (with 7 deaths) of MERS-CoV infection
associated with the South Korean outbreak
3
. Over two thirds of all confirmed cases have been reported from St. Mary's Hospital,
a 400 bed facility in Gyeonggi Province, Seoul and at least 14 facilities have reported
MERS cases during the outbreak. This unusually large number of secondary (80 cases)
and tertiary (14 cases) associated with an imported case of MERS by a traveller is
a significant development (as per 11th June 2015). Furthermore, whilst the Korea outbreak
has focussed global attention, a nosocomial outbreak of MERS in Hufoof, Saudi Arabia
has been on going since 20 Apr 2015 and resulted in 26 cases over the past 3 weeks
4
. There continue to be MERS cases reported from Jeddah and Riyadh, which are “sporadic”
community cases. To date Saudi Arabia has reported 1026 MERS cases including 450 deaths
(44 percent) since the first MERS case was reported in September, 2012.
The South Korean and Hufoof outbreaks raise several important concerns:
First the Korean outbreak emphasizes that MERS-CoV remains a major threat to global
health security and could have epidemic potential with time, even in the absence of
virus mutation.
Second the nature of the virus and its evolution into a more virulent form continues
to need close monitoring. Genomic sequencing studies of MERS-CoV obtained from the
first Korean case published by the Chinese Center for Disease Control and Prevention
5
has shown homology with MERS-CoV strains originating from Saudi Arabia. Whilst no
significant variation has been identified it remains crucial that genomic studies
for as many MERS cases as possible are performed.
Third, up to a million pilgrims from over 182 countries will travel to Mecca, Saudi
Arabia for the Ramadan period which begins on June 18th 2015 and the threat of further
global spread remains.
Fourth, for the past 18 months, MERS and other global infectious diseases threats
were totally overshadowed by the Ebola virus disease epidemic
6
, highlighting the inadequacies of global surveillance systems to focus concurrently
on several emerging and re-emerging infectious diseases simultaneously.
Fifth, many basic questions about the epidemiology, pathogenesis and management of
MERS-CoV remain to be answered
8
.
Sixth, it's been 3 years since MERS was identified as a lethal new viral respiratory
infection of humans
9
and primary cases of MERS-CoV infection continue to occur throughout the year
7
in the Middle East. The South Korean outbreak now illustrates the need to enhance
MERS-CoV surveillance systems, and heightens global awareness of MERS and the importance
of infection control measures.
Finally, the Korean outbreak emphasizes the importance of individuals, especially
healthcare workers, recognizing that they may have been exposed to MERS patients and
seeking medical care and self-quarantining at an early time during the disease course.
Moving forward, it is critical that global efforts are focussed urgently on the basic
science and on clinical and public health research so that the exact mode of transmission
to and between humans, and new drugs and other therapeutic interventions and vaccines
can be developed6, 7. Two coronaviruses, SARS-CoV and now MERS-CoV, which cause severe
respiratory disease with high mortality rates emerged within the past two decades
10
, reinforcing the need for clinically efficacious antivirals targeting coronaviruses.
Lessons learnt from the recent Ebola Virus Disease could also be applied to MERS
11
. Whilst MERS does not yet constitute an International Public Health Emergency the
Korean outbreak is an extraordinary event. Previous estimates of the epidemic potential
of MERS-CoV have not found that it had pandemic potential
12
, suggesting that airborne, human-to-human transmission is rare, but the present outbreak
indicates that simple hygiene is important, especially in health care facilities.
The index patient arrived at a health care system that was able to identify MERS as
a risk given his travel itinerary and had the laboratory resources to rapidly identify
the virus.
With continuing spread of MERS-CoV to countries outside the Middle East and to all
continents, MERS remains a public health risk and possible consequences of further
international spread could be serious in view of the patterns of nosocomial transmission
within healthcare facilities. Further spread to countries with weak health systems
and laboratory facilities unable to rapidly identify an unexpected virus may result
in a widespread outbreak or an epidemic in many of the 182 countries from which Ramadan,
Hajj and Umrah pilgrims originate.
Declaration: Authors declare no conflicts of interest.
A previously unknown coronavirus was isolated from the sputum of a 60-year-old man who presented with acute pneumonia and subsequent renal failure with a fatal outcome in Saudi Arabia. The virus (called HCoV-EMC) replicated readily in cell culture, producing cytopathic effects of rounding, detachment, and syncytium formation. The virus represents a novel betacoronavirus species. The closest known relatives are bat coronaviruses HKU4 and HKU5. Here, the clinical data, virus isolation, and molecular identification are presented. The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.
Summary Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary camels, hosts for MERS-CoV, are implicated in direct or indirect transmission to human beings, although the exact mode of transmission is unknown. The virus was first isolated from a patient who died from a severe respiratory illness in June, 2012, in Jeddah, Saudi Arabia. As of May 31, 2015, 1180 laboratory-confirmed cases (483 deaths; 40% mortality) have been reported to WHO. Both community-acquired and hospital-acquired cases have been reported with little human-to-human transmission reported in the community. Although most cases of MERS have occurred in Saudi Arabia and the United Arab Emirates, cases have been reported in Europe, the USA, and Asia in people who travelled from the Middle East or their contacts. Clinical features of MERS range from asymptomatic or mild disease to acute respiratory distress syndrome and multiorgan failure resulting in death, especially in individuals with underlying comorbidities. No specific drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities. MERS-CoV continues to be an endemic, low-level public health threat. However, the virus could mutate to have increased interhuman transmissibility, increasing its pandemic potential.
This review compares the clinical features, laboratory aspects and treatment options of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS).
Title:
International Journal of Infectious Diseases
Publisher:
Published by Elsevier Ltd.
ISSN
(Print):
1201-9712
ISSN
(Electronic):
1878-3511
Publication date PMC-release: 10
June
2015
Publication date
(Print):
July
2015
Publication date
(Electronic):
10
June
2015
Volume: 36
Pages: 54-55
Affiliations
[a
]Department of Infectious Diseases and Clinical Microbiology, Aarhus University Hospital
Skejby, Aarhus, Denmark
[b
]Division of Respiratory Medicine and Stanley Ho Center for Emerging Infectious Diseases,
The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative
Region, China
[c
]Departments of Microbiology and Pediatrics, University of Iowa, Iowa City, IA, USA
[d
]Division of Infection and Immunity, University College London, and NIHR Biomedical
Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.